Obamacare Alternative Hit With Crackdown by Biden Agencies
The Biden administration plans to issue a final rule on Thursday to curb the sale and availability of “short-term limited-duration insurance” plans, which critics say provide low-cost, but low-quality, coverage that skirts consumer protections in the Affordable Care Act.
Novo’s $1,000 Diabetes Drug Can Be Made for Under $5 a Month
Ozempic could be profitably produced for less than $5 a month even as maker
Landmark Washington Health Data Privacy Law Creates Suit Risks
Businesses dealing with health-related data in Washington state will be subject to new litigation and enforcement risks next week, as a far-reaching health privacy law takes effect.
Ninth Circuit Slams Idaho AG for Not Defending Abortion Letter
A panel of federal appeals court judges slammed the Idaho attorney general’s lawyer for failing to argue that a lawsuit brought by abortion providers is wrong on the merits.
AstraZeneca Sues to Block Arkansas Contract Pharmacy Law
Pharmaceutical giant AstraZeneca is seeking to block an Arkansas law that prohibits manufacturers from placing restrictions on pharmacies that take part in a federal drug discount program.
PRACTITIONER INSIGHTS
View More InsightsLatest Stories
Intra-Cellular Sues to Stop 7 Copies of Its Only Drug, Caplyta
Intra-Cellular Therapies Inc. filed lawsuits seeking to block copies of Caplyta proposed by Sandoz Group and six other generic-drug makers, alleging infringement of as many as 16 patents for the bipolar depression and schizophrenia treatment.
Teva Hits Amarin With Antitrust Lawsuit Over Generic Competition
Teva Pharmaceuticals is challenging Amarin Pharma Inc., alleging it entered exclusive agreements with active pharmaceutical ingredient suppliers to maintain exclusivity and exclude or delay potential competitors to its drug Vascepa.
Medicare Proposes Rate Hikes for Nursing Homes, Hospices
Nursing homes, hospice providers, and inpatient psychiatric facilities would all see Medicare pay hikes next year under proposals released Thursday by the Biden administration.
Liquidia Can Launch Yutrepia Lung-Disease Drug, a Blow to UTC
Liquidia Corp. can launch its Yutrepia lung-disease drug after a Delaware federal judge agreed to remove part of his 2022 judgment blocking final approval, a blow to
Medtronic Shakes Investor Claims Over Insulin Pump Problems
Medtronic PLC investors failed to state claims for security fraud tied to the device maker’s statements about allegedly flawed models of its MiniMed insulin pumps, a federal court ruled Thursday.
Prison Medical Bankruptcy Judge to Rule Soon on Case’s Future
A bankruptcy judge said he plans to rule in the coming weeks on the validity of prison healthcare provider Tehum Care Services Inc.'s bankruptcy and on a proposed settlement with prisoners.
Professor Wins Some Covid-Based Bias Claims Over In-Person Rule
Pennsylvania’s Kutztown University violated disability discrimination law when it repeatedly denied a business professor’s requests to teach remotely as an accommodation for an eye condition that left her at greater risk from the Covid-19 virus, a federal judge ruled.
Florida Man Pleads Guilty to Role in $4.6 Million Kickback Scam
A Florida man has admitted his role in a $4.6 million Medicare kickback and bribe conspiracy, according to the Justice Department Thursday.
Becton Dickinson Worker Mostly Advances Discrimination Lawsuit
A former
Beyond Abortion: The Fight Over Fetal Personhood Is Here
When do legal rights begin, at birth or before that? This video looks at the fetal personhood movement, and what it could mean for the future of abortion. We explore its history and the constitutional argument underpinning it.
From Across Bloomberg Law
- Business & Practice
- Environment & Energy Report
- Environmental, Social & Governance (ESG)
- The United States Law Week
Wake Up Call: Hogan Lovells Advises on $1.7 Billion Orioles Sale
Welcome to Bloomberg Law’s Wake Up Call, a daily rundown of the top news for lawyers, law firms, and in-house counsel.
Syngenta Pulls China IPO Application After Three-Year Wait (1)
<-bsp-bb-link state="{"bbHref":"bbg://securities/1844795D%20CH%20Equity","_id":"0000018e-89d1-d457-ad9e-dfd11c530000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">Syngenta Group-bsp-bb-link> withdrew its long-delayed application for a $9 billion initial public offering in Shanghai, another blow to China’s equity markets after Alibaba Group Holding Ltd. this week <-bsp-bb-link state="{"bbDocId":"SAYI8KT0G1KW","_id":"0000018e-89d1-d457-ad9e-dfd11c530001","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">scrapped-bsp-bb-link> the listing of its logistics arm.
SBF’s Letters of Support Do Little to Sway Judge at Sentencing
JetBlue Winds Down Relationship With New CEO’s Former Law Firm
The longstanding association between Holland & Knight and
Biden Scrutiny of Labor Competition Extends to Bank Noncompetes
The Federal Deposit Insurance Corp.'s updated bank merger guidelines for the first time seek to ban noncompete clauses in employment contracts when banks are eyeing deals, extending the Biden administration’s focus on labor market competition.
Leave These Harmful Narratives Behind to Advance Women in Law
Attorney Megan Gray takes on narratives about women in Big Law, and advocates for structural changes to boost gender equity in the legal industry.
Covid Vaccine & Personal Data: Does HIPAA Still Matter?
EXPLORE BLOOMBERG LAW
Get the latest legal, regulatory, and enforcement news and analysis, as well as in-depth business and industry covering in the following areas: